OBJECTIVE: Core2 1-6-N-glucosaminyltransferase-I (C2GlcNAcT-I) modification of adhesion molecules is required for optimal binding to target ligands. The objective of this study was to determine the role of C2GlcNAcT-I in the recruitment of Ly-6C(hi) monocytes to atherosclerotic lesions and in lesion formation in mice. METHODS AND RESULTS: In a whole-blood binding assay, Ly-6C(hi) monocytes and certain lymphocytes and natural killer cells from wild-type mice bound to P- and E-selectin. C2GlcNAcT-I deficiency abrogated leukocyte binding to P- and E-selectin in this assay as well as in an in vitro flow chamber assay. Moreover, C2GlcNAcT-I deficiency decreased Ly-6C(hi) monocyte interactions with atherosclerotic arteries under physiological flow conditions and also inhibited monocyte recruitment to the peritoneal cavity in mice challenged with thioglycollate. In apolipoprotein E-deficient (apoE(-/-)) mice, lack of C2GlcNAcT-I resulted in fewer and smaller atherosclerotic lesions in mouse aortas. Atherosclerosis was also suppressed in C2GlcNAcT-I(-/-)/apoE(-/-) chimeric mice transplanted with C2GlcNAcT-I(+/+) bone marrow cells. CONCLUSIONS: C2GlcNAcT-I in both leukocytes and blood vessel wall cells contributes to leukocyte recruitment to the arterial wall. C2GlcNAcT-I deficiency leads to the formation of small, macrophage-poor, and collagen-rich atherosclerotic lesions.
OBJECTIVE: Core2 1-6-N-glucosaminyltransferase-I (C2GlcNAcT-I) modification of adhesion molecules is required for optimal binding to target ligands. The objective of this study was to determine the role of C2GlcNAcT-I in the recruitment of Ly-6C(hi) monocytes to atherosclerotic lesions and in lesion formation in mice. METHODS AND RESULTS: In a whole-blood binding assay, Ly-6C(hi) monocytes and certain lymphocytes and natural killer cells from wild-type mice bound to P- and E-selectin. C2GlcNAcT-I deficiency abrogated leukocyte binding to P- and E-selectin in this assay as well as in an in vitro flow chamber assay. Moreover, C2GlcNAcT-I deficiency decreased Ly-6C(hi) monocyte interactions with atherosclerotic arteries under physiological flow conditions and also inhibited monocyte recruitment to the peritoneal cavity in mice challenged with thioglycollate. In apolipoprotein E-deficient (apoE(-/-)) mice, lack of C2GlcNAcT-I resulted in fewer and smaller atherosclerotic lesions in mouse aortas. Atherosclerosis was also suppressed in C2GlcNAcT-I(-/-)/apoE(-/-) chimeric mice transplanted with C2GlcNAcT-I(+/+) bone marrow cells. CONCLUSIONS: C2GlcNAcT-I in both leukocytes and blood vessel wall cells contributes to leukocyte recruitment to the arterial wall. C2GlcNAcT-I deficiency leads to the formation of small, macrophage-poor, and collagen-rich atherosclerotic lesions.
Authors: Yuqing Huo; Andreas Schober; S Bradley Forlow; David F Smith; Matthew Craig Hyman; Steffen Jung; Dan R Littman; Christian Weber; Klaus Ley Journal: Nat Med Date: 2002-12-16 Impact factor: 53.440
Authors: Jian Guo; Vivian de Waard; Miranda Van Eck; Reeni B Hildebrand; Eva J A van Wanrooij; Johan Kuiper; Nobuyo Maeda; G Martin Benson; Pieter H E Groot; Theo J C Van Berkel Journal: Arterioscler Thromb Vasc Biol Date: 2005-03-17 Impact factor: 8.311
Authors: Lijun Xia; Vishwanath Ramachandran; J Michael McDaniel; Kiem N Nguyen; Richard D Cummings; Rodger P McEver Journal: Blood Date: 2002-08-29 Impact factor: 22.113
Authors: A S Weyrich; M R Elstad; R P McEver; T M McIntyre; K L Moore; J H Morrissey; S M Prescott; G A Zimmerman Journal: J Clin Invest Date: 1996-03-15 Impact factor: 14.808
Authors: Erica L Stone; Mohd Nazri Ismail; Seung Ho Lee; Ying Luu; Kevin Ramirez; Stuart M Haslam; Samuel B Ho; Anne Dell; Minoru Fukuda; Jamey D Marth Journal: Mol Cell Biol Date: 2009-04-06 Impact factor: 4.272
Authors: Huan Wang; Weiyu Zhang; Rong Tang; Robert P Hebbel; M Anna Kowalska; Chunxiang Zhang; Jamey D Marth; Minoru Fukuda; Chuhong Zhu; Yuqing Huo Journal: Arterioscler Thromb Vasc Biol Date: 2009-04-16 Impact factor: 8.311